US 9492405
Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
granted A61KA61K31/137A61K45/06
Quick answer
US patent 9492405 (Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/137, A61K45/06, A61P, A61P35/00